peptuity.

WhatsApp

Head to head

Compare compounds

Head-to-head comparisons on the evidence.

BPC-157 vs TB-500

EmergingEmerging

BPC-157 vs GHK-Cu

EmergingWell researched

Semaglutide vs Tirzepatide

FDA approvedFDA approved

Tirzepatide vs Retatrutide

FDA approvedWell researched

Semaglutide vs Retatrutide

FDA approvedWell researched

Ipamorelin vs Sermorelin

EmergingWell researched

CJC-1295 (no DAC) vs Ipamorelin

EmergingEmerging

Tesamorelin vs Sermorelin

FDA approvedWell researched

Semax vs Selank

EmergingEmerging

Melanotan I vs PT-141

Well researchedFDA approved

Epitalon vs NAD+

Limited evidenceEmerging

Thymosin Alpha-1 vs LL-37

Well researchedEmerging

Kisspeptin-10 vs HCG

Well researchedFDA approved

Looking for stacks?

Marketed blends are documented separately.

Marketed stacks →

Research use only

All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.